Galapagos buys Argenta to strengthen discovery services
Belgium-based Galapagos NV has acquired Argenta Discovery for €16.5m ($23.1m), creating a drug discovery service company with 390 employees and estimated revenues of €70m.
Belgium-based Galapagos NV has acquired Argenta Discovery for €16.5m ($23.1m), creating a drug discovery service company with 390 employees and estimated revenues of €70m.
Pall Life Sciences plans to shake up bioprocessing with a vibration-based filtering tech that can cut costs and simplify process design by combining harvest and clarification in the same system.
Biofem Pharmaceuticals and NAFDAC have launched an anti-counterfeiting pilot project in Nigeria, using a mobile authentication service (MAS) to validate if a medicine is genuine.
ClearTrial says information is power in trial talks and claims its CTO software helped biotech firm save 20 per cent of bid cost through more informed negotiations with its CRO.
Demand for disposable bioprocessing tech helped Millipore to a comfortable Q4, cementing the recovery made by the unit throughout 2009.
CRO Novella Clinical is providing OSI Pharmaceuticals with clinical research and related services over the next two years and will gain use of facilities in Boulder, Colorado, US as part of the deal.
Seidenader Maschinenbau has developed a system which can check up to 600 syringes per minute for pierced needle shields.